CT in malignancy grading and prognostic prediction of non-Hodgkin's lymphoma

Acta Radiologica

Volumn 40, Issue 2, 1999, Pages 191-197

  Rodriguez, Miriam ^a   Rehn, S M ^b   Nyman, R S ^b   Sundstrom J C ^b   Ahlstrom H ^b   Glimelius, B L G ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

CT; Malignancy grade; Non Hodgkin's lymphoma; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, HIGH-GRADE; LYMPHOMA, LOW-GRADE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033089038     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859909177737     Document Type: Article

References (18)

1. AISENBERG A. C.: Coherent view of non-Hodgkin's lymphoma. J. Clin. Oncol. 13 (1995), 2656.
2. ARMITAGE J. O.: Drug therapy. Treatment of non-Hodgkin's lymphoma. N. Engl. J. Med. 328 (1993), 1023.
3. CARBONE P. P., KAPLAN H. S., MUSSHOFF K. et al.: Report of the Committee in Hodgkin's Disease Staging Classification. Cancer Res. 31 (1971), 1860.
4. COIFFIER B.: Fourteen years of high-dose CHOP (ACVB regimen). Preliminary conclusions about the treatment of aggressive-lymphoma patients. Ann. Oncol. 6 (1995), 211.
5. COX D. R.: Regression models and life tables (with discussion). J. Roy. State Soc. B. 34 (1972), 187.
6. HARRIS N. L., JAFFE E. S., STEIN H. et al.: A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 84 (1994), 1361.
7. HOPPE R. T.: Histologic variation in non-Hodgkin's lymphomas. Cancer Treat. Reports 11 (1981), 935.
8. HORNING S. J.: Low-grade lymphoma 1993. State of the art. Ann. Oncol. 5 Suppl. 2 (1993), 23.
9. LESKINEN-KALLIO S., RUOTSALAINEN U., NÅGREN K. et al.: Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma. A PET study. J. Nucl. Med. 32 (1991), 1211.
10. MEUSERS P., HENSE J. & BRITTINGER G.: Mantle cell lymphoma. Diagnostic criteria, clinical aspects and therapeutic problems. Leukemia 11, Suppl. 2 (1997), 60.
11. REHN S., GLIMELIUS B. & SUNDSTRÖM C.: A comparative study of proliferation-associated parameters in B-cell non-Hodgkin lymphomas. Hematol. Oncol. 9 (1991), 287.
12. REHN S., NYMAN R., GLIMELIUS B. et al.: Magnetic resonance imaging for predicting prognostic grade in non-Hodgkin lymphomas. Radiology 176 (1990), 249.
13. REHN S., RODRIGUEZ M., BERGSTRÖM R. et al.: Tumour inhomogeneities on MR imaging, a new factor with prognostic information in non-Hodgkin lymphomas. Leuk. Lymphoma 24 (1997), 501.
14. REHN S., SPERBER G., NYMAN R. et al.: Quantification of inhomogeneities in malignancy grading of non-Hodgkin lymphomas with MR imaging. Acta Radiol. Diagn. 34 (1993), 3.
15. RODRIGUEZ M., REHN S., AHLSTRÖM H. et al.: Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J. Nucl. Med. 36 (1995), 1790.
16. SHIPP M. A., HARRINGTON D. P., ANDERSSON J. R. et al.: A predictive model for aggressive non-Hodgkin's lymphoma. N. Engl. J. Med. 329 (1993), 987.
17. STANSFELD A., DIEBOLD J., KAPANCI Y. et al.: Updated Kiel classification for lymphomas. Lancet Feb. (1988), 292.
18. TUBIANA M.: Repopulations in human tumors. A biological background for fractionation in radiotherapy. Acta Oncol. 27 (1988), 83.